[Skip to Navigation]
April 1989


Arch Intern Med. 1989;149(4):940. doi:10.1001/archinte.1989.00390040136030

Incorrect Abbreviation.—xIn the article titled "The Place of HDL in Cholesterol Management," published in the March Archives (1989;149:505-510), there was an incorrect abbreviation. On page 505, in the 11th line of the abstract, following (2), "LDL-cholesterol" should have read "HDL-cholesterol." The abstract should have read as follows: "The guidelines developed by the Adult Treatment Panel of the National Cholesterol Education Program identified low density lipoprotein (LDL) as the major atherogenic lipoprotein, and high levels of LDL-cholesterol as the primary target for cholesterol-lowering therapy. Low levels of high density lipoprotein (HDL)-cholesterol were recognized as a major risk factor for coronary heart disease. This report reexamines in depth the recommendations of the Adult Treatment Panel on HDL-cholesterol. Two major questions are discussed: (1) Should HDL-cholesterol levels be measured in all adults, as recommended for total cholesterol? (2) Should patients found to have a low serum HDL-cholesterol level (<35 mg/dL [<0.91 mmol/L]) enter medical

Add or change institution